Diabetes drugs are the biggest culprit when it comes to off-label claims in direct-to-consumer TV advertising, according to a study by Yale University researchers published in the Journal of General Internal Medicine Feb. 26.
Of 97 unique TV ads reviewed in the study, the 13 with misleading off-label claims were all for diabetes drugs,...